BeiGene, Ltd. , a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.